Clinical Trial Update: Huperzine A in Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of huperzine A for Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Huperzine A (Huperzine A)

Snippet

Sponsor: National Institute on Aging (NIA) | Conditions: Alzheimer Disease | Phase 2 | Status: COMPLETED